Head-to-head · WeighScore
MadeMed vs Vaylen
By GLP-1 ScorecardUpdated
Score comparison
MadeMed has the higher recorded score — 80.4/100 to 77.9/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
Before you choose
Before comparing the headline prices, the MadeMed review and the Vaylen review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, MadeMed vs Vea Health and OnlyRx vs Vaylen compare each of them with another graded program, and the list of alternatives to MadeMed ranks the programs closest to MadeMed on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Strut Health review covers one graded close to these two, at 79.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MadeMed | Vaylen |
|---|---|---|
| WeighScore | 80.4/100 | 77.9/100 |
| Grade | B− | C+ |
| Site position | #35 | #45 |
| Semaglutide | $179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmation | $99/mo advertised (monthly option; conflicting annual totals) |
| Tirzepatide | Injection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverified | From $99/mo (12-month prepaid equivalent; monthly-plan price not confirmed) |
| Coverage | Confirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverified | Public disclosures differ between 49 and 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #35 · B−
Strengths
- Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
- Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
- Current terms name MDI Medical Group PC and four partner pharmacy brands
- A 30-day purchase is advertised alongside the larger prepaid options
What to consider
- Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
- Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
- The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
- Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
Strengths
- Shows a separate month-to-month semaglutide option
- Advertises injectable and oral compounded options
- Describes cancellation through the patient portal for monthly plans
What to consider
- The annual semaglutide card shows $828 and the FAQ states $996
- The offer and terms describe different payment timing and clinical groups
- Confirm coverage, the dispensing pharmacy and any named branded drug with the provider
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.